Connection and Networking
Make the most of your time and take part in the many opportunities for peer-to-peer discussions, collaboration, and discussion on selected topics.
Shared Interest Group (SIG) Meetups
SIG meetups offer a unique opportunity to connect with like-minded peers on a specific topic, fostering collaboration and conversation.
Wednesday | 9:45 AM – 10:45 AM
- Genetic Counselor SIG
- Phenotypes, Genotypes, & Disease Biology SIG
Thursday | 9:45 AM – 10:45 AM
- Computational Genomics, AI, & Statistical Genetics SIG
Friday | 9:45 AM– 10:45 AM
- Emerging Omics & Clinical Translational Research SIG
Ethical and Cultural Implications: Navigating the Future of Genomics Research Luncheon
Wednesday | 12:00 PM – 1:30 PM
Curious about how human genomics can move forward responsibly and inclusively? Join us for an open conversation about the ethical and cultural considerations shaping the field today. This session will examine what makes informed consent meaningful across different contexts, the structural barriers to research, and how to mitigate the risks of emerging technologies. We’ll also explore community-centered approaches to help ensure that genomic advances benefit people everywhere.
Engagement and Belonging Community Conversations
Thursday | 9:45 AM – 10:45 AM
Join colleagues from around the globe for an interactive session centered on authentic community dialogue. This is your chance to slow down, share your perspective, and hear from others in a supportive, inclusive environment. Whether you’re looking to exchange ideas, gain new insights, or simply connect with peers, these conversations are designed to be thoughtful, energizing, and welcoming to all.
Community Conversations: Scientific Communication
Thursday | 1:30 PM – 2:15 PM
Join your peers for an extension of the 2026 Presidential Symposium, where ASHG President Susan A. Slaughenhaupt and the full panel lead an open, in-depth conversation about scientific communication. This community conversation will explore the opportunities, challenges, and evolving approaches to sharing scientific discoveries with diverse audiences, while exchanging ideas and perspectives in an engaging, interactive discussion. All attendees are welcome.
Advocates in Action: ACGT Presentations and Networking Event
Friday | 9:45 AM – 10:45 AM
See how the next generation of advocates is shaping the policy landscape. During this session, ACGT Program participants will present their capstone advocacy projects, each designed to advance the responsible integration of human genetics and genomics into public policy.
Following the presentations, join colleagues and peers for a networking session connecting anyone interested in ASHG advocacy, including current trainees, ACGT alumni, and incoming participants. It’s an ideal space to learn about ASHG advocacy priorities, exchange insights, explore collaboration opportunities, and see how you can get involved.
2026 Behind the Scenes: ASHG Publications Workshop
Friday | 12:00 PM – 1:30 PM
Join us for an interactive workshop designed to demystify the scientific publishing process and equip you with practical insights for getting your work into print. This session features small group discussions led by experienced journal editors who will share candid, behind-the-scenes perspectives on how editorial decisions are made, what makes a manuscript stand out, and common pitfalls to avoid.
You’ll have ample opportunity to ask questions and engage directly with editors from leading genetics journals, including AJHG and HGG Advances, in an informal, conversational setting. This workshop is ideal for trainees and early-career faculty who are new to scientific publishing and looking to build confidence, skills, and connections within the editorial community.
The Future of Gene Therapy: Policy Pathways for Safe, Scalable Innovation
Friday | 1:30 PM – 2:30 PM
This policy forum will bring together experts across disciplines to examine the policy, economic, and ethical opportunities for accelerating safe and affordable gene therapies.
Discussion will focus on scaling individualized therapies, evaluating global regulatory approaches to gene editing and gene therapy, and exploring the FDA’s “plausible mechanism” pathway for expedited review.